These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 22983107)

  • 1. Lymphopaenia, anti-Ro/anti-RNP autoantibodies, renal involvement and cyclophosphamide use correlate with increased risk of herpes zoster in patients with systemic lupus erythematosus.
    Hu SC; Lin CL; Lu YW; Chen GS; Yu HS; Wu CS; Lan CC
    Acta Derm Venereol; 2013 May; 93(3):314-8. PubMed ID: 22983107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Herpes zoster in systemic lupus erythematosus.
    Manzi S; Kuller LH; Kutzer J; Pazin GJ; Sinacore J; Medsger TA; Ramsey-Goldman R
    J Rheumatol; 1995 Jul; 22(7):1254-8. PubMed ID: 7562754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Herpes zoster infection in childhood-onset systemic lupus erythematosus patients: a large multicenter study.
    Ferreira JC; Marques HH; Ferriani MP; Gormezano NW; Terreri MT; Pereira RM; Magalhães CS; Campos LM; Bugni V; Okuda EM; Marini R; Pileggi GS; Barbosa CM; Bonfá E; Silva CA
    Lupus; 2016 Jun; 25(7):754-9. PubMed ID: 26821966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphopenia as risk factor for development of severe infections in patients with systemic lupus erythematosus: a case-control study.
    Merayo-Chalico J; Gómez-Martín D; Piñeirúa-Menéndez A; Santana-De Anda K; Alcocer-Varela J
    QJM; 2013 May; 106(5):451-7. PubMed ID: 23458779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunosuppressive medication use and risk of herpes zoster (HZ) in patients with systemic lupus erythematosus (SLE): A nationwide case-control study.
    Hu SC; Yen FL; Wang TN; Lin YC; Lin CL; Chen GS
    J Am Acad Dermatol; 2016 Jul; 75(1):49-58. PubMed ID: 26946984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence, risk factors, and outcome of Herpes zoster in systemic lupus erythematosus.
    Borba EF; Ribeiro AC; Martin P; Costa LP; Guedes LK; Bonfá E
    J Clin Rheumatol; 2010 Apr; 16(3):119-22. PubMed ID: 20216330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-actinin-binding antibodies in relation to systemic lupus erythematosus and lupus nephritis.
    Becker-Merok A; Kalaaji M; Haugbro K; Nikolaisen C; Nilsen K; Rekvig OP; Nossent JC
    Arthritis Res Ther; 2006; 8(6):R162. PubMed ID: 17062137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A surge in anti-dsDNA titer predicts a severe lupus flare within six months.
    Pan N; Amigues I; Lyman S; Duculan R; Aziz F; Crow MK; Kirou KA
    Lupus; 2014 Mar; 23(3):293-8. PubMed ID: 24316605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Herpes zoster infections in systemic lupus erythematosus: risk factors and outcome.
    Kahl LE
    J Rheumatol; 1994 Jan; 21(1):84-6. PubMed ID: 8151595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adrenomedullin--a potential disease activity marker and suppressor of nephritis activity in systemic lupus erythematosus.
    Mak A; Cheung BM; Mok CC; Leung R; Lau CS
    Rheumatology (Oxford); 2006 Oct; 45(10):1266-72. PubMed ID: 16595522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zoster after Cyclophosphamide for Systemic Lupus Erythematosus or Vasculitis: Incidence, Risk Factors, and Effect of Antiviral Prophylaxis.
    Garnier C; Ribes D; Chauveau D; Huart A; Pugnet G; Adoue D; Prevot G; Alric L; Delobel P; Derumeaux H; Mengelle C; Sailler L; Moulis G
    J Rheumatol; 2018 Nov; 45(11):1541-1548. PubMed ID: 30008461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Herpes zoster in juvenile-onset systemic lupus erythematosus: incidence, clinical characteristics and risk factors.
    Lee PP; Lee TL; Ho MH; Wong WH; Lau YL
    Pediatr Infect Dis J; 2006 Aug; 25(8):728-32. PubMed ID: 16874173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Juvenile-onset systemic lupus erythematosus: different clinical and serological pattern than adult-onset systemic lupus erythematosus.
    Hoffman IE; Lauwerys BR; De Keyser F; Huizinga TW; Isenberg D; Cebecauer L; Dehoorne J; Joos R; Hendrickx G; Houssiau F; Elewaut D
    Ann Rheum Dis; 2009 Mar; 68(3):412-5. PubMed ID: 18930995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-nucleosome antibodies as a disease marker in systemic lupus erythematosus and its correlation with disease activity and other autoantibodies.
    Pradhan VD; Patwardhan MM; Ghosh K
    Indian J Dermatol Venereol Leprol; 2010; 76(2):145-9. PubMed ID: 20228543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between anti-Ro/La titers and clinical findings of patients with systemic lupus erythematosus.
    Chien JW; Lin CY; Yang LY
    Zhonghua Yi Xue Za Zhi (Taipei); 2001 May; 64(5):283-91. PubMed ID: 11499338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphopenia is associated with neuropsychiatric manifestations and disease activity in paediatric systemic lupus erythematosus patients.
    Yu HH; Wang LC; Lee JH; Lee CC; Yang YH; Chiang BL
    Rheumatology (Oxford); 2007 Sep; 46(9):1492-4. PubMed ID: 17673480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological aspects of biopsy-proven lupus nephritis in Bahraini patients with systemic lupus erythematosus.
    Farid EM; Hassan AB; Abalkhail AA; El-Agroudy AE; Arrayed SA; Al-Ghareeb SM
    Saudi J Kidney Dis Transpl; 2013 Nov; 24(6):1271-9. PubMed ID: 24231503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and risk factors of herpes zoster infection in patients with biopsy proven lupus nephritis undergoing immunosuppressive therapies.
    Mok CC; Tse SM; Chan KL; Ho LY
    Lupus; 2020 Jul; 29(8):836-844. PubMed ID: 32408851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and genetic risk factors of herpes zoster in patients with systemic lupus erythematosus.
    Kang TY; Lee HS; Kim TH; Jun JB; Yoo DH
    Rheumatol Int; 2005 Mar; 25(2):97-102. PubMed ID: 14593495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations of clinical features and prognosis with age at disease onset in patients with systemic lupus erythematosus.
    Feng X; Zou Y; Pan W; Wang X; Wu M; Zhang M; Tao J; Zhang Y; Tan K; Li J; Chen Z; Ding X; Qian X; Da Z; Wang M; Sun L
    Lupus; 2014 Mar; 23(3):327-34. PubMed ID: 24297642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.